Funding opportunity for pediatric Ewing sarcoma research – St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn:
“Funding Opportunity: Pediatric Ewing Sarcoma Research.
We’re seeking groundbreaking research proposals for relapsed, metastatic Ewing sarcoma with the goal of rapidly advancing to a Phase 1 clinical trial. If your work could lead to high-impact treatments and cures, apply now!
LOI Deadline: February 26, 2025 (5 PM ET).
This $1.395 million (over 3 years) Advancing Cures for Ewing Sarcoma (ACES) grant is administered by the St. Baldrick’s Foundation and supported by the Sam Day Foundation, The Faris Foundation, Rutledge Cancer Foundation, Alan B. SLifka Foundation Inc, and The Shohet Family Fund for Ewing Sarcoma Research (a St. Baldrick’s Foundation Hero Fund).
Learn more and apply today!”
More posts featuring St. Baldrick’s Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023